Surinder K Batra Selected Research

Pancreatic Neoplasms (Pancreatic Cancer)

11/2022	Chemokine-mucinome interplay in shaping the heterogeneous tumor microenvironment of pancreatic cancer.
1/2022	The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells.
1/2022	Mucin 5AC Serves as the Nexus for β-Catenin/c-Myc Interplay to Promote Glutamine Dependency During Pancreatic Cancer Chemoresistance.
1/2022	Mucin 5AC-Mediated CD44/ITGB1 Clustering Mobilizes Adipose-Derived Mesenchymal Stem Cells to Modulate Pancreatic Cancer Stromal Heterogeneity.
1/2022	Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies.
1/2022	Fluorescent Anti-MUC5AC Brightly Targets Pancreatic Cancer in a Patient-derived Orthotopic Xenograft.
1/2022	MUC16 Promotes Liver Metastasis of Pancreatic Ductal Adenocarcinoma by Upregulating NRP2-Associated Cell Adhesion.
1/2022	Endothelin-axis antagonism enhances tumor perfusion in pancreatic cancer.
11/2021	Correction: Kaushal et al. Repurposing Niclosamide for Targeting Pancreatic Cancer by Inhibiting Hh/Gli Non-Canonical Axis of Gsk3β. Cancers 2021, 13, 3105.
10/2021	Nanoscale platform for delivery of active IRINOX to combat pancreatic cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Surinder K Batra Research Topics

Disease

239	Neoplasms (Cancer) 11/2022 - 12/2002
104	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 01/2002
83	Neoplasm Metastasis (Metastasis) 11/2022 - 11/2003
51	Adenocarcinoma 11/2022 - 01/2002
38	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 03/2002
32	Carcinogenesis 11/2022 - 07/2004
18	Inflammation (Inflammations) 01/2020 - 04/2004
13	Disease Progression 11/2022 - 01/2006
13	Chronic Pancreatitis 10/2022 - 10/2002
12	Carcinoma (Carcinomatosis) 02/2018 - 03/2006
11	Lung Neoplasms (Lung Cancer) 10/2022 - 08/2010
11	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 03/2016
11	Ovarian Neoplasms (Ovarian Cancer) 12/2019 - 06/2007
9	Squamous Cell Carcinoma of Head and Neck 12/2021 - 11/2012
7	Colonic Neoplasms (Colon Cancer) 10/2022 - 01/2014
6	Breast Neoplasms (Breast Cancer) 10/2022 - 04/2011
6	Pancreatitis 10/2022 - 03/2008
6	Glioblastoma (Glioblastoma Multiforme) 10/2021 - 09/2011
5	Lymphatic Metastasis 01/2020 - 11/2012
4	Circulating Neoplastic Cells 10/2022 - 01/2011
4	Neoplasms, Cystic, Mucinous, and Serous 10/2021 - 03/2004
4	Hypoxia (Hypoxemia) 07/2016 - 01/2012
4	Genomic Instability 02/2013 - 01/2003
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2022 - 01/2020
3	Metaplasia 10/2021 - 04/2004
3	Mesothelioma 01/2020 - 02/2004
3	Adenocarcinoma of Lung 10/2019 - 02/2004

Drug/Important Bio-Agent (IBA)

86	MucinsIBA 11/2022 - 01/2002
47	Biomarkers (Surrogate Marker)IBA 10/2022 - 10/2006
44	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2002
26	Pharmaceutical PreparationsIBA 01/2022 - 01/2002
20	AndrogensIBA 01/2020 - 03/2002
19	MicroRNAs (MicroRNA)IBA 01/2022 - 06/2010
17	AntigensIBA 01/2021 - 12/2002
16	ErbB Receptors (EGF Receptor)IBA 10/2020 - 05/2004
15	Biological ProductsIBA 12/2021 - 08/2006
13	Glycoproteins (Glycoprotein)IBA 01/2021 - 09/2005
12	CytokinesIBA 11/2022 - 06/2003
12	AntibodiesIBA 10/2022 - 02/2004
12	CateninsIBA 01/2022 - 08/2011
11	Messenger RNA (mRNA)IBA 01/2022 - 02/2004
11	Monoclonal AntibodiesIBA 01/2021 - 01/2002
11	Polysaccharides (Glycans)IBA 03/2020 - 01/2011
10	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2015 - 01/2003
10	Hormones (Hormone)IBA 08/2011 - 03/2002
9	EnzymesIBA 01/2020 - 10/2002
8	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 01/2006
8	LigandsIBA 01/2022 - 07/2004
8	SmokeIBA 12/2021 - 04/2004
7	Phosphotransferases (Kinase)IBA 01/2022 - 04/2009
7	Gemcitabine FDA Link 01/2022 - 11/2005
7	Epidermal Growth Factor (EGF)IBA 01/2020 - 05/2004
7	EpitopesIBA 01/2018 - 01/2002
6	Mucin-4IBA 10/2022 - 05/2010
6	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 05/2010
6	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2002
6	IntegrinsIBA 11/2020 - 03/2007
6	Docetaxel (Taxotere)FDA Link 11/2020 - 03/2007
6	Lipocalin-2IBA 11/2020 - 09/2010
6	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2016 - 01/2008
6	Cadherins (E-Cadherin)IBA 02/2014 - 04/2007
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2009
5	Neuropilin-2IBA 01/2022 - 01/2016
5	Transcription Factors (Transcription Factor)IBA 12/2021 - 04/2009
5	AfatinibIBA 10/2021 - 03/2015
5	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2019 - 04/2008
5	Small Interfering RNA (siRNA)IBA 01/2018 - 04/2007
5	Gefitinib (Iressa)FDA Link 03/2010 - 02/2006
4	ChemokinesIBA 11/2022 - 02/2013
4	CarcinogensIBA 01/2022 - 01/2003
4	NexusIBA 01/2022 - 03/2016
4	Neoplasm Antigens (Tumor Antigens)IBA 01/2021 - 04/2003
4	RNA Polymerase II (RNA Polymerase B)IBA 11/2020 - 01/2011
4	Tyrosine Kinase InhibitorsIBA 10/2020 - 02/2006
4	CarbohydratesIBA 10/2018 - 04/2003
4	Nicotine FDA Link 09/2012 - 07/2009
4	Transforming Growth Factor beta (TGF-beta)IBA 09/2010 - 07/2004
4	cyclopamineIBA 03/2010 - 02/2006
4	Single-Chain AntibodiesIBA 09/2005 - 03/2003
3	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 04/2022 - 01/2016
3	Mucin 5ACIBA 01/2022 - 01/2021
3	Indicators and Reagents (Reagents)IBA 12/2021 - 04/2015
3	NF-kappa B (NF-kB)IBA 12/2021 - 08/2011
3	Chemokine ReceptorsIBA 12/2021 - 01/2016
3	Temozolomide (Temodar)FDA LinkGeneric 10/2021 - 06/2019
3	Amyloid (Amyloid Fibrils)IBA 03/2021 - 02/2015
3	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021 - 11/2017
3	PaxillinIBA 11/2020 - 05/2016
3	CeruletideIBA 11/2020 - 03/2008
3	Cisplatin (Platino)FDA LinkGeneric 08/2020 - 01/2014
3	Tamoxifen FDA LinkGeneric 01/2020 - 01/2007
3	GlycosyltransferasesIBA 01/2020 - 12/2015
3	epidermal growth factor receptor VIIIIBA 06/2019 - 09/2011
3	LectinsIBA 11/2018 - 10/2012

Therapy/Procedure

102	Therapeutics 01/2022 - 05/2003
17	Drug Therapy (Chemotherapy) 05/2021 - 09/2010
15	Radiotherapy 11/2022 - 09/2010
11	Immunotherapy 11/2022 - 03/2012
7	Castration 01/2022 - 01/2015
6	Radioimmunotherapy 01/2019 - 12/2002